ash 2015: ibrutinib as first-line treatment for chronic lymphocytic leukaemia
Published 8 years ago • 792 plays • Length 8:13Download video MP4
Download video MP3
Similar videos
-
6:55
ibrutinib plus venetoclax for first-line treatment of chronic lymphocytic leukaemia
-
6:47
ibrutinib venetoclax for first-line treatment of chronic lymphocytic leukaemia (cll)/small lym...
-
11:23
captivate: fixed-duration first-line treatment with ibrutinib plus venetoclax for cll/sll
-
4:04
ibrutinib plus venetoclax for the first-line treatment of cll/sll: results from the captivate study
-
5:29
ibrutinib to treat elderly patients with chronic lymphocytic leukaemia
-
4:59
comparing outcomes of first-line ibrutinib vs chemoimmunotherapy in high-risk cll
-
4:22
added ibrutinib in first-line cll treatment
-
10:41
captivate: first-line ibrutinib plus venetoclax for cll/sll
-
7:36
fixed-duration ibrutinib and venetoclax for first-line cll
-
14:03
asco 2015: latest in chronic lymphocytic leukaemia
-
12:53
selecting first-line treatment for chronic lymphocytic leukemia (cll)
-
4:27
ibrutinib with obinutuzumab in patients with chronic lymphocytic leukaemia
-
3:02
resonate-2: five-year follow up of cll patients receiving ibrutinib as first-line treatment
-
1:07
ibrutinib plus venetoclax as a treatment option for cll
-
1:56
ibrutinib plus venetoclax for first-line treatment of cll: 4-year follow-up data
-
6:39
ibrutinib venetoclax for chronic lymphocytic leukemia (cll) treatment - dr. bill wierda ash 2022
-
1:17
dose reductions to manage aes of ibrutinib treatment for cll
-
5:27
ibrutinib as a frontline therapy in resonate2 trials for cll
-
25:38
cll: chemotherapy and ibrutinib based regimens